This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why G-III Apparel (GIII) is a Solid Investment Bet
by Zacks Equity Research
G-III Apparel's (GIII) brand power and solid business strategies, including restructuring initiatives, appear encouraging. Its digital business also looks good.
Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWO
Crocs (CROX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Crocs (CROX) closed the most recent trading day at $112.43, moving +0.9% from the previous trading session.
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will Crocs (CROX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Crocs (CROX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTWG
Wolverine's (WWW) Strategies Look Encouraging, Up 32.4% YTD
by Zacks Equity Research
Wolverine (WWW) is focused on strengthening its direct-to-consumer business. The company also reinforces its presence across international markets.
Crocs (CROX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Crocs (CROX) closed at $107.13, marking a +0.05% move from the previous day.
Crocs (CROX) to Ride on Solid Demand & HEYDUDE Amid Cost Woes
by Zacks Equity Research
Crocs (CROX) is likely to gain from rising consumer demand, innovation and brand strength, despite inflation and supply-chain headwinds.
CROX vs. LVMUY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CROX vs. LVMUY: Which Stock Is the Better Value Option?
Should Value Investors Buy Crocs (CROX) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FuboTV (FUBO) Teams Up With Seattle Mariners for 2023 Season
by Zacks Equity Research
FuboTV (FUBO) reveals a marketing collaboration with the Seattle Mariners for the upcoming 2023 season.
Steven Madden's (SHOO) Strategic Efforts Appear Encouraging
by Zacks Equity Research
Steven Madden's (SHOO) e-commerce efforts appear encouraging. The company has ramped up digital marketing spending and rolled out buy online and pick up in store across its outlets.
Marriott (MAR) on Fire: What's Driving the Stock Higher?
by Zacks Equity Research
Marriott (MAR) benefits from acceleration in international RevPAR, expansion efforts and digital initiatives.
Crocs (CROX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Crocs (CROX) closed at $107.06, marking a -1.4% move from the previous day.
Here's Why Skechers (SKX) is a Promising Investment Bet Now
by Zacks Equity Research
Skechers (SKX) is gaining on solid direct-to-consumer sales and comfort technology footwear. Its international business also appears encouraging.
Factors That Emphasize Royal Caribbean's (RCL) Solid Prospects
by Zacks Equity Research
Royal Caribbean (RCL) benefits from robust booking trends, addition of new ships and focus on Trifecta Program.
Here's Why G-III Apparel (GIII) is a Solid Investment Bet
by Zacks Equity Research
G-III Apparel's (GIII) brand power and solid business strategies, including restructuring initiatives, appear encouraging. Its digital business also looks good.
Stride's (LRN) MedCerts Unveils Healthcare Courses via Coursera
by Zacks Equity Research
Stride's (LRN) MedCerts joins Coursera for its healthcare courses and expands its reach.
Marriott's (MAR) Ritz-Carlton Reserve Brand Debuts in China
by Zacks Equity Research
Marriott's (MAR) luxury brand Ritz-Carlton Reserve debuts in China with an 87-villa resort, Rissai Valley.
Under Armour (UAA) Rides High on Growth Strategies: Apt to Hold
by Zacks Equity Research
Under Armour (UAA) is strengthening its brands through enhanced customer connections, effective innovations and a loyalty program.
Central Garden & Pet (CENT) Grapples With Multiple Headwinds
by Zacks Equity Research
Central Garden & Pet (CENT) witnesses softness in its garden and pet segments. A tough operating landscape is also a deterrent.
Wolverine (WWW) Riding High on Growth Strategies: Apt to Hold
by Zacks Equity Research
Wolverine (WWW) is focused on strengthening its direct-to-consumer business. The company also reinforces its presence across international markets.
Lincoln (LINC) Completes Nashville Campus Divestiture to SLC
by Zacks Equity Research
Lincoln's (LINC) planned divestiture of the Nashville campus is in line with its business strategy.
Match Group (MTCH) Tackles Dating App Burnout With New Feature
by Zacks Equity Research
Match Group (MTCH) introduces a feature to give date-ready members an opportunity to meet other serious singles in real life sooner.